Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

In vitro skin absorption and drug release - a comparison of six commercial prednicarbate preparations for topical use.

Lombardi Borgia S, Schlupp P, Mehnert W, Schäfer-Korting M.

Eur J Pharm Biopharm. 2008 Feb;68(2):380-9. Epub 2007 May 13.

PMID:
17574402
2.

Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids.

Schlupp P, Blaschke T, Kramer KD, Höltje HD, Mehnert W, Schäfer-Korting M.

Skin Pharmacol Physiol. 2011;24(4):199-209. doi: 10.1159/000324053. Epub 2011 Feb 24.

PMID:
21346400
3.

Drug targeting by solid lipid nanoparticles for dermal use.

Santos Maia C, Mehnert W, Schaller M, Korting HC, Gysler A, Haberland A, Schäfer-Korting M.

J Drug Target. 2002 Sep;10(6):489-95.

PMID:
12575739
4.

Esterase activity in excised and reconstructed human skin--biotransformation of prednicarbate and the model dye fluorescein diacetate.

Bätz FM, Klipper W, Korting HC, Henkler F, Landsiedel R, Luch A, von Fritschen U, Weindl G, Schäfer-Korting M.

Eur J Pharm Biopharm. 2013 Jun;84(2):374-85. doi: 10.1016/j.ejpb.2012.11.008. Epub 2012 Nov 29.

PMID:
23201050
5.

Solid lipid nanoparticles as drug carriers for topical glucocorticoids.

Maia CS, Mehnert W, Schäfer-Korting M.

Int J Pharm. 2000 Mar 10;196(2):165-7.

PMID:
10699710
6.

Skin penetration and metabolism of topical glucocorticoids in reconstructed epidermis and in excised human skin.

Gysler A, Kleuser B, Sippl W, Lange K, Korting HC, Höltje HD, Korting HC.

Pharm Res. 1999 Sep;16(9):1386-91.

PMID:
10496654
7.

[Galenic and clinico-pharmacologic studies of prednicarbate (Hoe 777)].

Petri W, Frosch PJ, Savopoulos C, Rupp W, Sittig W.

Z Hautkr. 1986;61 Suppl 1:62-73. German.

PMID:
3705674
8.

[Pharmacokinetics and biotransformation following topical use of the local corticoid prednicarbate].

Kellner HM, Eckert HG, Fehlhaber HW, Hornke I, Oekonomopulos R.

Z Hautkr. 1986;61 Suppl 1:18-40. German.

PMID:
3705671
9.
10.

Albumin effects on drug absorption and metabolism in reconstructed epidermis and excised pig skin.

Haberland A, Santos Maia C, Jores K, Dürrfeld M, Mehnert W, Schimke I, Christ B, Schäfer-Korting M.

ALTEX. 2003;20(1):3-9.

11.

Prednicarbate biotransformation in human foreskin keratinocytes and fibroblasts.

Gysler A, Lange K, Korting HC, Schäfer-Korting M.

Pharm Res. 1997 Jun;14(6):793-7.

PMID:
9210199
12.

Studies on the pharmacokinetics and metabolism of prednicarbate after cutaneous and oral administration.

Barth J, Lehr KH, Derendorf H, Möllmann HW, Höhler T, Hochhaus G.

Skin Pharmacol. 1993;6(3):179-86.

PMID:
8274287
13.

Study of tolnaftate release from fatty acids containing ointment and penetration into human skin ex vivo.

Kezutyte T, Drevinskas T, Maruska A, Rimdeika R, Briedis V.

Acta Pol Pharm. 2011 Nov-Dec;68(6):965-73.

14.

[Experimental results of the optimization of external prednisolone therapy].

Wohlrab W, Taube KM, Wozniak KD.

Pharmazie. 1987 Jun;42(6):400-2. German.

PMID:
3671461
15.
16.

Prednicarbate activity and benefit/risk ratio in relation to other topical glucocorticoids.

Schäfer-Korting M, Korting HC, Kerscher MJ, Lenhard S.

Clin Pharmacol Ther. 1993 Oct;54(4):448-56.

PMID:
8222488
17.

Reconstructed epidermis and full-thickness skin for absorption testing: influence of the vehicles used on steroid permeation.

Schäfer-Korting M, Mahmoud A, Lombardi Borgia S, Brüggener B, Kleuser B, Schreiber S, Mehnert W.

Altern Lab Anim. 2008 Sep;36(4):441-52.

PMID:
18826333
18.

Dermal penetration and metabolism of p-aminophenol and p-phenylenediamine: application of the EpiDerm human reconstructed epidermis model.

Hu T, Bailey RE, Morrall SW, Aardema MJ, Stanley LA, Skare JA.

Toxicol Lett. 2009 Jul 24;188(2):119-29. doi: 10.1016/j.toxlet.2009.03.019. Epub 2009 Mar 31.

PMID:
19446244
19.

Comparative permeation studies of nondiluted and diluted betamethasone-17-valerate semisolid formulations through isolated human stratum corneum and artificial skin construct.

Mitriaikina S, Muller-Goymann CC.

Skin Pharmacol Physiol. 2009;22(3):142-50. doi: 10.1159/000203368. Epub 2009 Feb 21.

PMID:
19246962
20.

Prednicarbate versus conventional topical glucocorticoids: pharmacodynamic characterization in vitro.

Lange K, Gysler A, Bader M, Kleuser B, Korting HC, Schäfer-Korting M.

Pharm Res. 1997 Dec;14(12):1744-9.

PMID:
9453063

Supplemental Content

Support Center